Personal profile
Research interests
Related documents
Education/Academic qualification
PhD in Neuroscience, PhD, University of Cambridge
2001
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 3 Finished
-
The Role of Relaxin in Alleviating Type 2 Diabetes Mellitus Symptoms and Providing Neuroprotection Against Parkinson’s Disease.
CHUNG, K. K. (PI), TSIM, K. W. K. (CoI) & YUE, S. (CoI)
Innovation and Technology Commission, ALSKY-Z Pharma Limited
1/11/22 → 31/10/24
Project: Research
-
A Stem Cell Approach to Dissect the Molecular Basis of Neurodegenerative Diseases
CHUNG, K. K. (CoI), WU, Z. (CoPI), FU, K. Y. (CoPI), IP, N.Y.-Y. (PI), TSIM, K. W. K. (CoI), WONG, Y. H. (CoPI), FENG, B. (CoI), QU, J. (CoPI), HE, J. (CoI), XIA, J. (CoPI), LAI, K. O. (CoPI), ZHANG, M. (CoPI), QI, R. Z. (CoPI), CHEUNG, T. (CoPI), YUNG, W. H. (CoPI), WEN, Z. (CoPI) & IP, J. P. K. (CoI)
RGC - Theme-based Research Scheme
1/01/19 → 31/12/24
Project: Research
-
The establishment of a novel Parkinson's disease mouse model by conditional expression of aggregation-prone alpha-synuclein in dopaminergic neurons
CHUNG, K. K. (PI)
1/01/18 → 30/06/21
Project: Research
-
ICG-001 Provides Cardioprotection Against Doxorubicin-Induced Cardiotoxicity and Enhances Cancer Cytotoxicity
Wu, B., Chen, J. C. H., Ma, C. H. Y., Kwok, M., Chan, V. T., Sung, C. C., Song, Y., Zhang, T., Lam, H. S., Meng, F., Liang, Y., Tsoi, C., Deng, R., Tsui, S. K. W., Leung, K. T., Wang, C. C., Chan, G. C. F., Boheler, K. R., Chung, K. K. K. & Poon, E. N., Feb 2026, In: JACC: Basic to Translational Science. 11, 2, 101459.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Age-dependent alpha-synuclein aggregation and Lewy body formation in Parkinson's disease
Sung, C. C. & Chung, K. K. K., Dec 2025, In: Neural Regeneration Research. 20, 12, p. 3533-3534 2 p.Research output: Contribution to journal › Journal Article › peer-review
3 Link opens in a new tab Citations (Scopus) -
一種天然蛋白分子在製備抗帕金森氏症候群的藥物中的應用 Application of a natural protein molecule in the preparation of drugs against Parkinson's syndrome
TSIM, K. W. K., CHUNG, K. K. K., SUNG, C. C., LIN, S. & YU, S., 2025Research output: Other contribution › peer-review
-
The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation
LI, J., NG, K. W., SUNG, C. C. & CHUNG, K. K., 21 Jun 2024, In: Journal of Neurochemistry. 168, 7, p. 1215-1236 22 p., 38693066.Research output: Contribution to journal › Journal Article › peer-review
Open Access5 Link opens in a new tab Citations (Scopus) -
The role of polo-like kinases 2 in the proteasomal and lysosomal degradation of alpha-synuclein in neurons
Sung, C. C., Lam, W. Y. & Chung, K. K. K., Oct 2024, In: FASEB Journal. 38, 20, e70121.Research output: Contribution to journal › Journal Article › peer-review
2 Link opens in a new tab Citations (Scopus)